USP10沉默在改良兔青光眼滤过手术模型中防止瘢痕形成和炎症
该研究在兔青光眼滤过手术模型中测试USP10沉默(sdRNA US09)对滤过泡瘢痕和炎症的影响。体外实验显示US09降低USP10表达并抑制肌成纤维细胞活化;体内单次US09剂量减少术后凋亡,且与MMC相比,US09保留滤过泡结构、持续免疫抑制并避免缺血性血管化。结论认为围手术期USP10靶向sdRNA可能是有前景的抗瘢痕策略。
要点
- US09在体外抑制RTF的肌成纤维细胞转化并降低α-SMA和纤连蛋白表达。
- 单次US09减少术后凋亡,效果优于NTC和MMC。
- US09保留滤过泡结构并持续免疫抑制,避免MMC相关缺血性血管化。
核心结论
- 围手术期USP10靶向sdRNA减少肌成纤维细胞发展并维持抗炎、组织保护表型,在组织保护和炎症终点上优于MMC。
- USP10沉默可能是有前景的抗瘢痕策略以改善长期小梁切除术结局。
研究设计与样本
- 体外实验:原代兔Tenon成纤维细胞(RTF)转染靶向USP10的自递送siRNA(sdRNA,US09)或非靶向对照sdRNA(NTC),评估肌成纤维细胞转化和纤连蛋白表达。
- 体内实验:雌性新西兰白兔接受改良青光眼滤过手术并置管,结膜下注射US09、NTC或丝裂霉素C(MMC)。
- 评估指标包括滤过泡健康和血管化评分(改良Moorfields系统)、眼压(TonoVet Plus)、滤过泡组织宽度、凋亡(TUNEL)、α-SMA和CD45+细胞浸润,以及房水炎症细胞因子(ELISA)。
主要发现
- US09转染RTF降低USP10表达,抑制肌成纤维细胞活化,降低α-SMA和纤连蛋白表达并破坏纤维组织。
- 体内单次US09剂量减少术后凋亡,优于NTC和MMC。
- US09和MMC均抑制肌成纤维细胞分化和早期免疫浸润,但仅US09保留滤过泡结构、持续免疫抑制并避免MMC相关缺血性血管化。
- US09治疗与房水中几种细胞因子平均水平降低相关。
临床怎么用
- USP10靶向sdRNA可能作为围手术期抗瘢痕策略,用于改善小梁切除术后的滤过泡存活。
- 与MMC相比,US09在组织保护和炎症控制方面可能具有优势,但需进一步临床验证。
局限性
- 研究为兔模型,结果向人类转化需谨慎。
- 样本量和具体数值未在摘要中报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Trabeculectomy remains the gold standard for lowering intraocular pressure (IOP) in glaucoma, but postoperative scarring and inflammation can cause bleb failure. Because USP10 knockdown is anti-inflammatory and anti-fibrotic in the cornea, we tested whether USP10 silencing reduces bleb scarring and inflammation in a rabbit glaucoma filtration surgery model. METHODS: Primary rabbit Tenon's fibroblasts (RTFs) were transfected with fully modified in vivo self-delivering siRNA targeting USP10 (sdRNA, US09) or non-targeting control sdRNA (NTC) to assess myofibroblast conversion and fibronectin expression. Female New Zealand White rabbits underwent modified glaucoma filtering surgery with tube insertion and subconjunctival US09, NTC, or mitomycin C (MMC). Bleb health and vascularity were scored using a modified Moorfields system, IOP was measured with TonoVet Plus, and excised blebs were analyzed for tissue width, apoptosis (TUNEL), α-SMA, and CD45+ cell infiltration. Inflammatory cytokines were profiled from aqueous humor by ELISA. RESULTS: US09 transfection in RTFs reduced USP10 expression and suppressed myofibroblast activation, lowering α-SMA and fibronectin expression and disrupting fibrillar organization. In vivo, a single US09 dose reduced postoperative apoptosis versus NTC and MMC. Although both US09 and MMC inhibited myofibroblast differentiation and early immune infiltration, only US09 preserved bleb architecture, sustained immune suppression, and avoided MMC-associated ischemic vascularity. US09 treatment was also associated with lower mean levels of several aqueous humor cytokines. CONCLUSIONS: Perioperative USP10-targeting sdRNA reduced myofibroblast development and sustained an anti-inflammatory, tissue-preserving phenotype after rabbit glaucoma filtration surgery, with advantages over MMC in tissue-preservation and inflammatory endpoints. USP10 silencing may represent a promising anti-scarring strategy to improve long-term trabeculectomy outcomes.
引用
- Tilstra-Smith C, Castro N, Shaik MA, et al. USP10 Silencing Prevents Scarring and Inflammation in a Modified Rabbit Model of Glaucoma Filtration Surgery. Invest Ophthalmol Vis Sci. 2026. PMID: 42904888. doi:10.1167/iovs.67.12.38
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。